Literature DB >> 28948408

Association between primary biliary cholangitis and osteoporosis: meta-analysis.

Junyu Fan1, Qian Wang2, Lingyun Sun3,4.   

Abstract

The relationship between primary biliary cholangitis (PBC, previously termed primary biliary cirrhosis) and risks of osteoporosis remains controversial. This meta-analysis was designed to comprehensively analyze the association between PBC and osteoporosis. We conducted a systematic literature search of the PubMed, EMBASE, and Web of Science. Either fixed or random effects models were applied to assess bone mineral density (BMD), osteoporosis rates, and fractures in PBC patients and normal controls. A total of eight studies were included (including 1643 PBC patients and 10,921 controls). PBC patients had a relative risk (RR) of 2.79 (95% CI 1.26 to 6.16) for the development of osteoporosis, lower lumbar spine BMD (95% CI - 0.13 to - 0.04, P = 0.0002), hip BMD (95% CI - 0.13 to - 0.03, P = 0.002), and lumbar spine t score (95% CI - 1.69 to - 1.02, P < 0.00001) than controls. Moreover, PBC patients had an OR of 1.86 (95%CI 1.54 to 2.24, P < 0.00001) for the development of fractures. Collectively, this meta-analysis indicates that PBC patients were more likely to suffer from osteoporosis. Given the limited literature available, better designed and larger scale primary studies will be required to confirm our conclusion.

Entities:  

Keywords:  Meta-analysis; Osteoporosis; Primary biliary cholangitis

Mesh:

Year:  2017        PMID: 28948408     DOI: 10.1007/s10067-017-3844-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  Is osteoporosis a peculiar association with primary biliary cirrhosis?

Authors:  Annarosa Floreani; Andrea Mega; Valentina Camozzi; Vincenzo Baldo; Mario Plebani; Patrizia Burra; Giovanni Luisetto
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

3.  Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.

Authors:  Núria Guañabens; Albert Parés; Inmaculada Ros; Llorenç Caballería; Francesca Pons; Sergi Vidal; Ana Monegal; Pilar Peris; Juan Rodés
Journal:  J Hepatol       Date:  2005-01-13       Impact factor: 25.083

4.  Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

Authors:  A Cemborain; I Castilla-Cortázar; M García; B Muguerza; G Delgado; M Díaz-Sánchez; A Picardi
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

5.  Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease.

Authors:  S Ormarsdóttir; O Ljunggren; H Mallmin; H Olofsson; W F Blum; L Lööf
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

6.  Osteoporosis: still a typical complication of primary biliary cirrhosis?

Authors:  E Solerio; G Isaia; R Innarella; M Di Stefano; M Farina; E Borghesio; L Framarin; M Rizzetto; F Rosina
Journal:  Dig Liver Dis       Date:  2003-05       Impact factor: 4.088

7.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.

Authors:  C H Janes; E R Dickson; R Okazaki; S Bonde; A F McDonagh; B L Riggs
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

Review 9.  Osteoporosis in primary biliary cirrhosis of the liver.

Authors:  Joanna Raszeja-Wyszomirska; Tomasz Miazgowski
Journal:  Prz Gastroenterol       Date:  2014-05-05

10.  Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis.

Authors:  Ferenc Szalay; Aniko Folhoffer; Andrea Horváth; Timea Csak; Gabor Speer; Zsolt Nagy; Peter Lakatos; Csaba Horváth; Andrzej Habior; Istvan Tornai; Peter Laszlo Lakatos
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-09       Impact factor: 2.566

View more
  4 in total

Review 1.  Secondary Osteoporosis and Metabolic Bone Diseases.

Authors:  Mahmoud M Sobh; Mohamed Abdalbary; Sherouk Elnagar; Eman Nagy; Nehal Elshabrawy; Mostafa Abdelsalam; Kamyar Asadipooya; Amr El-Husseini
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

2.  Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases.

Authors:  Yoshitaka Arase; Kota Tsuruya; Shunji Hirose; Naoki Ogiwara; Masashi Yokota; Kazuya Anzai; Ryuzo Deguchi; Koichi Shiraishi; Takayuki Shirai; Tatehiro Kagawa
Journal:  Hepatology       Date:  2019-10-10       Impact factor: 17.425

3.  Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis.

Authors:  Chisato Saeki; Tsunekazu Oikawa; Kaoru Ueda; Masanori Nakano; Yuichi Torisu; Masayuki Saruta; Akihito Tsubota
Journal:  Diagnostics (Basel)       Date:  2022-08-12

4.  APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.

Authors:  Hong You; Xiong Ma; Cumali Efe; Guiqiang Wang; Sook-Hyang Jeong; Kazumichi Abe; Weijia Duan; Sha Chen; Yuanyuan Kong; Dong Zhang; Lai Wei; Fu-Sheng Wang; Han-Chieh Lin; Jin Mo Yang; Tawesak Tanwandee; Rino A Gani; Diana A Payawal; Barjesh C Sharma; Jinlin Hou; Osamu Yokosuka; A Kadir Dokmeci; Darrell Crawford; Jia-Horng Kao; Teerha Piratvisuth; Dong Jin Suh; Laurentius A Lesmana; Jose Sollano; George Lau; Shiv K Sarin; Masao Omata; Atsushi Tanaka; Jidong Jia
Journal:  Hepatol Int       Date:  2022-02-04       Impact factor: 6.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.